Orgenesis Inc. (ORGS) OTC

0.90

-0.1(-10.00%)

Updated at August 18 10:02AM

Currency In USD

Orgenesis Inc.

Address

20271 Goldenrod Lane

Germantown, MD 20876

United States of America

Phone

480 659 6404

Sector

Healthcare

Industry

Biotechnology

Employees

146

First IPO Date

March 13, 2012

Key Executives

NameTitlePayYear Born
Ms. Vered Caplan M.Sc.Chairperson of the Board, Chief Executive Officer & President341,3841969
Prof. Sarah Ferber Ph.D.Founder & Chief Scientific Officer268,3191954
Dr. Shimon Hassin Ph.D.Chief Technology Officer0N/A
Mr. Victor MillerChief Financial Officer, Secretary & Treasurer01970

Description

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.